世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）の世界市場インサイト、2030年までの予測Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Insights, Forecast to 2030 FVRCP（猫ウイルス性鼻気管炎、カリシウイルス、汎白血球減少症）は、猫ウイルス性鼻気管炎（猫ヘルペス）、カリシウイルス、猫汎白血球減少症（猫ジステンパー）から猫を守る混合ワクチンです。 世界のFVRCP（... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーFVRCP（猫ウイルス性鼻気管炎、カリシウイルス、汎白血球減少症）は、猫ウイルス性鼻気管炎（猫ヘルペス）、カリシウイルス、猫汎白血球減少症（猫ジステンパー）から猫を守る混合ワクチンです。世界のFVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）市場は、2024年の100万米ドルから2030年には100万米ドルまで、予測期間中の年間平均成長率（CAGR）%で成長すると予測されています。 FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）の米国・カナダ市場は、2024年の100万ドルから2030年には100万ドルに達すると予測され、2024年から2030年までの予測期間中、年平均成長率（CAGR）は％である。 FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）の中国市場は、2024年の100万ドルから2030年には100万ドルに達すると推定され、2024年から2030年までの予測期間中のCAGRは％である。 FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）の欧州市場は、2024年の100万ドルから2024年から2030年の予測期間中に年平均成長率（CAGR）％で増加し、2030年には100万ドルに達すると推定されています。 FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）の世界の主要メーカーは、Zoetis、Boehringer Ingelheim、Merck、Tianjin Rinpuなどである。2023年、世界の上位5社の売上シェアは約 %であった。 レポートの内容 FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）の世界市場概要、売上、収益、価格を紹介します。2019年～2023年の過去の市場収益/売上データ、2024年の推定値、2030年までのCAGR予測で世界市場動向を分析。 FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）の主要生産者を調査し、主要地域・国の売上高も掲載しています。FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点のハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。 本レポートでは、FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）の売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当て、2019年から2024年までのデータを掲載しています。世界のFVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）市場における主要ステークホルダーの特定、および最近の動向とセグメント別の収益に基づく競争環境と市場ポジショニングの分析。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。 本レポートでは、2019年から2030年までのセグメントデータをタイプ別、用途別、売上高、収益、価格で分析しています。FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）の売上高、予測成長動向、生産技術、用途、エンドユーザー産業の評価と市場規模予測。 Zoetis社、Boehringer Ingelheim社、Merck社、Tianjin Rinpu社など、世界の主要企業の詳細な企業プロフィール 市場セグメンテーション 企業別 ゾエティス ベーリンガーインゲルハイム メルク 天津林普 タイプ別 生ワクチン 不活化ワクチン 用途別セグメント 8週齢以上 12週齢以上 地域別セグメント 米国およびカナダ 米国 カナダ 中国 アジア（中国を除く） 日本 韓国 中国 台湾 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東、アフリカ、中南米 ブラジル メキシコ トルコ イスラエル GCC諸国 各章の概要 第1章：報告書のスコープ、各市場セグメント（タイプ別、用途別など）の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。 第2章 FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）の世界、地域レベル、国レベルでの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。 第3章：FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）メーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。 第4章：タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。 第5章：読者が異なる下流市場のブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーする、アプリケーション別の様々な市場セグメントの分析を提供します。 第6章 北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。 第7章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高、収益。 第8章：中国：タイプ別、用途別、セグメント別の売上高、収益。 第9章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。 第10章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。 第11章：主要メーカーのプロフィールを提供し、製品の説明や仕様、FVRCP（猫ウイルス性鼻気管炎-カリシ-汎白血球減少症ワクチン）の売上高、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。 第12章：産業チェーン、販売チャネル、主要原材料、流通業者と顧客の分析。 第13章：市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。 第14章：レポートの要点と結論。 目次1 Study Coverage1.1 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product Introduction 1.2 Market by Type 1.2.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 1.2.2 Live Attenuated Vaccine 1.2.3 Inactivated Vaccine 1.3 Market by Application 1.3.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 1.3.2 8 Weeks and Older 1.3.3 12 Weeks and Older 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Estimates and Forecasts 2019-2030 2.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region 2.2.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region: 2019 VS 2023 VS 2030 2.2.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region (2019-2024) 2.2.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region (2025-2030) 2.2.4 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Region (2019-2030) 2.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Estimates and Forecasts 2019-2030 2.4 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region 2.4.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region: 2019 VS 2023 VS 2030 2.4.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region (2019-2024) 2.4.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region (2025-2030) 2.4.4 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Region (2019-2030) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufacturers 3.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Manufacturers 3.1.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Manufacturers (2019-2024) 3.1.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Manufacturers (2019-2024) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) in 2023 3.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Manufacturers 3.2.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Manufacturers (2019-2024) 3.2.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Manufacturers (2019-2024) 3.2.3 Global Top 10 and Top 5 Companies by FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue in 2023 3.3 Global Key Players of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine), Industry Ranking, 2021 VS 2022 3.4 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Price by Manufacturers (2019-2024) 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine), Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine), Product Offered and Application 3.8 Global Key Manufacturers of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine), Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Type 4.1.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Historical Sales by Type (2019-2024) 4.1.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Forecasted Sales by Type (2025-2030) 4.1.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Type (2019-2030) 4.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Type 4.2.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Historical Revenue by Type (2019-2024) 4.2.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Forecasted Revenue by Type (2025-2030) 4.2.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Type (2019-2030) 4.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price by Type 4.3.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price by Type (2019-2024) 4.3.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price Forecast by Type (2025-2030) 5 Market Size by Application 5.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Application 5.1.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Historical Sales by Application (2019-2024) 5.1.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Forecasted Sales by Application (2025-2030) 5.1.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Application (2019-2030) 5.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Application 5.2.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Historical Revenue by Application (2019-2024) 5.2.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Forecasted Revenue by Application (2025-2030) 5.2.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Application (2019-2030) 5.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price by Application 5.3.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price by Application (2019-2024) 5.3.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price Forecast by Application (2025-2030) 6 US & Canada 6.1 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Type 6.1.1 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Type (2019-2030) 6.1.2 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Type (2019-2030) 6.2 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Application 6.2.1 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Application (2019-2030) 6.2.2 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Application (2019-2030) 6.3 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Country 6.3.1 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 6.3.2 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2019-2030) 6.3.3 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2019-2030) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Type 7.1.1 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Type (2019-2030) 7.1.2 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Type (2019-2030) 7.2 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Application 7.2.1 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Application (2019-2030) 7.2.2 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Application (2019-2030) 7.3 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Country 7.3.1 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 7.3.2 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2019-2030) 7.3.3 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2019-2030) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Type 8.1.1 China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Type (2019-2030) 8.1.2 China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Type (2019-2030) 8.2 China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Application 8.2.1 China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Application (2019-2030) 8.2.2 China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Application (2019-2030) 9 Asia (excluding China) 9.1 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Type 9.1.1 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Type (2019-2030) 9.1.2 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Type (2019-2030) 9.2 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Application 9.2.1 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Application (2019-2030) 9.2.2 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Application (2019-2030) 9.3 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Region 9.3.1 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region: 2019 VS 2023 VS 2030 9.3.2 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region (2019-2030) 9.3.3 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region (2019-2030) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 9.3.9 Australia 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Type 10.1.1 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Type (2019-2030) 10.1.2 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Type (2019-2030) 10.2 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Application 10.2.1 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Application (2019-2030) 10.2.2 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Application (2019-2030) 10.3 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Country 10.3.1 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 10.3.2 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2019-2030) 10.3.3 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2019-2030) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Corporate Profile 11.1 Zoetis 11.1.1 Zoetis Company Information 11.1.2 Zoetis Overview 11.1.3 Zoetis FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales, Price, Revenue and Gross Margin (2019-2024) 11.1.4 Zoetis FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Zoetis Recent Developments 11.2 Boehringer Ingelheim 11.2.1 Boehringer Ingelheim Company Information 11.2.2 Boehringer Ingelheim Overview 11.2.3 Boehringer Ingelheim FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales, Price, Revenue and Gross Margin (2019-2024) 11.2.4 Boehringer Ingelheim FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Boehringer Ingelheim Recent Developments 11.3 Merck 11.3.1 Merck Company Information 11.3.2 Merck Overview 11.3.3 Merck FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales, Price, Revenue and Gross Margin (2019-2024) 11.3.4 Merck FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Merck Recent Developments 11.4 Tianjin Rinpu 11.4.1 Tianjin Rinpu Company Information 11.4.2 Tianjin Rinpu Overview 11.4.3 Tianjin Rinpu FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales, Price, Revenue and Gross Margin (2019-2024) 11.4.4 Tianjin Rinpu FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Tianjin Rinpu Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Industry Chain Analysis 12.2 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Production Mode & Process 12.4 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales and Marketing 12.4.1 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Channels 12.4.2 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Distributors 12.5 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Customers 13 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Dynamics 13.1 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Industry Trends 13.2 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Drivers 13.3 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Challenges 13.4 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Restraints 14 Key Findings in the Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Author Details 15.3 Disclaimer
SummaryFVRCP (Feline Viral Rhinotracheitis, Calicivirus, Panleukopenia) is a combination vaccine that protects cats against feline viral rhinotracheitis (feline herpes), calicivirus, and feline panleukopenia (feline distemper). Table of Contents1 Study Coverage1.1 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product Introduction 1.2 Market by Type 1.2.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 1.2.2 Live Attenuated Vaccine 1.2.3 Inactivated Vaccine 1.3 Market by Application 1.3.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 1.3.2 8 Weeks and Older 1.3.3 12 Weeks and Older 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Estimates and Forecasts 2019-2030 2.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region 2.2.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region: 2019 VS 2023 VS 2030 2.2.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region (2019-2024) 2.2.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region (2025-2030) 2.2.4 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Region (2019-2030) 2.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Estimates and Forecasts 2019-2030 2.4 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region 2.4.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region: 2019 VS 2023 VS 2030 2.4.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region (2019-2024) 2.4.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region (2025-2030) 2.4.4 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Region (2019-2030) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufacturers 3.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Manufacturers 3.1.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Manufacturers (2019-2024) 3.1.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Manufacturers (2019-2024) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) in 2023 3.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Manufacturers 3.2.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Manufacturers (2019-2024) 3.2.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Manufacturers (2019-2024) 3.2.3 Global Top 10 and Top 5 Companies by FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue in 2023 3.3 Global Key Players of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine), Industry Ranking, 2021 VS 2022 3.4 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Price by Manufacturers (2019-2024) 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine), Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine), Product Offered and Application 3.8 Global Key Manufacturers of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine), Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Type 4.1.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Historical Sales by Type (2019-2024) 4.1.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Forecasted Sales by Type (2025-2030) 4.1.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Type (2019-2030) 4.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Type 4.2.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Historical Revenue by Type (2019-2024) 4.2.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Forecasted Revenue by Type (2025-2030) 4.2.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Type (2019-2030) 4.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price by Type 4.3.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price by Type (2019-2024) 4.3.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price Forecast by Type (2025-2030) 5 Market Size by Application 5.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Application 5.1.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Historical Sales by Application (2019-2024) 5.1.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Forecasted Sales by Application (2025-2030) 5.1.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Application (2019-2030) 5.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Application 5.2.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Historical Revenue by Application (2019-2024) 5.2.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Forecasted Revenue by Application (2025-2030) 5.2.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Application (2019-2030) 5.3 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price by Application 5.3.1 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price by Application (2019-2024) 5.3.2 Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price Forecast by Application (2025-2030) 6 US & Canada 6.1 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Type 6.1.1 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Type (2019-2030) 6.1.2 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Type (2019-2030) 6.2 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Application 6.2.1 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Application (2019-2030) 6.2.2 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Application (2019-2030) 6.3 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Country 6.3.1 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 6.3.2 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2019-2030) 6.3.3 US & Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2019-2030) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Type 7.1.1 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Type (2019-2030) 7.1.2 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Type (2019-2030) 7.2 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Application 7.2.1 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Application (2019-2030) 7.2.2 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Application (2019-2030) 7.3 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Country 7.3.1 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 7.3.2 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2019-2030) 7.3.3 Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2019-2030) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Type 8.1.1 China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Type (2019-2030) 8.1.2 China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Type (2019-2030) 8.2 China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Application 8.2.1 China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Application (2019-2030) 8.2.2 China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Application (2019-2030) 9 Asia (excluding China) 9.1 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Type 9.1.1 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Type (2019-2030) 9.1.2 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Type (2019-2030) 9.2 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Application 9.2.1 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Application (2019-2030) 9.2.2 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Application (2019-2030) 9.3 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Region 9.3.1 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region: 2019 VS 2023 VS 2030 9.3.2 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region (2019-2030) 9.3.3 Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region (2019-2030) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 9.3.9 Australia 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Type 10.1.1 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Type (2019-2030) 10.1.2 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Type (2019-2030) 10.2 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Application 10.2.1 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Application (2019-2030) 10.2.2 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Application (2019-2030) 10.3 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Country 10.3.1 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 10.3.2 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2019-2030) 10.3.3 Middle East, Africa and Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2019-2030) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Corporate Profile 11.1 Zoetis 11.1.1 Zoetis Company Information 11.1.2 Zoetis Overview 11.1.3 Zoetis FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales, Price, Revenue and Gross Margin (2019-2024) 11.1.4 Zoetis FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Zoetis Recent Developments 11.2 Boehringer Ingelheim 11.2.1 Boehringer Ingelheim Company Information 11.2.2 Boehringer Ingelheim Overview 11.2.3 Boehringer Ingelheim FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales, Price, Revenue and Gross Margin (2019-2024) 11.2.4 Boehringer Ingelheim FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Boehringer Ingelheim Recent Developments 11.3 Merck 11.3.1 Merck Company Information 11.3.2 Merck Overview 11.3.3 Merck FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales, Price, Revenue and Gross Margin (2019-2024) 11.3.4 Merck FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Merck Recent Developments 11.4 Tianjin Rinpu 11.4.1 Tianjin Rinpu Company Information 11.4.2 Tianjin Rinpu Overview 11.4.3 Tianjin Rinpu FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales, Price, Revenue and Gross Margin (2019-2024) 11.4.4 Tianjin Rinpu FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Tianjin Rinpu Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Industry Chain Analysis 12.2 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Production Mode & Process 12.4 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales and Marketing 12.4.1 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Channels 12.4.2 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Distributors 12.5 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Customers 13 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Dynamics 13.1 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Industry Trends 13.2 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Drivers 13.3 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Challenges 13.4 FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Restraints 14 Key Findings in the Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート本レポートと同じKEY WORD（vaccine）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
